NEW YORK—The Food and Drug Administration alerted health care professionals that the heartburn medication Zantac and its generic form, ranitidine, contains a “probable human carcinogen.” The drug contains an impurity called NDMA which appeared in blood pressure and heart failure medicines that were previously recalled.
As of Oct. 3, over three dozen countries have recalled or banned the drug. Canada was the first to issue an outright ban and Taiwan is taking the strongest action, fining manufacturers that don’t comply with the recall order.
